Predictive factors for foot ulceration in diabetes: a follow-up

An evidence-based evaluation of the clinical and cost effectiveness of foot ulcer risk assessment and structured care interventions for people with diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN10550720

Enrollment

1192

Registered

2016-12-23

Start date

2016-03-01

Completion date

Unknown

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foot ulceration in diabetes Nutritional, Metabolic, Endocrine Foot ulceration is assessed by reviewing electronic patient records at baseline.

Interventions

Participants of this study are from a previous (unregistered) cohort study, available via https://www.ncbi.nlm.nih.gov/pubmed/21186178. This involved among all 3969 patients who were registered with t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 18 years or over 2. Diagnosis of diabetes mellitus 3. Ambulant 4. Free of foot ulceration 5. Able to give written informed consent 6. Having participating in previous cohort study (The risk of foot ulceration in people with diabetes screenedin community settings: findings from a cohort study), available to view via https://www.ncbi.nlm.nih.gov/pubmed/21186178

Exclusion criteria

Exclusion criteria: 1. Unable to give informed consent 2. Non ambulant

Design outcomes

Primary

Measure	Time frame
Foot ulceration is measured using routinely collected data and patient podiatry notes.	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

Scotland, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026